What is the appropriate treatment for headaches associated with viral meningitis due to herpes simplex virus type 2?

Treatment for Headaches Related to Viral Meningitis and HSV-2

For HSV-2 viral meningitis, start intravenous acyclovir 10 mg/kg every 8 hours immediately upon clinical suspicion or positive CSF findings, and continue for 14-21 days, with symptomatic management of headache using standard analgesics. 1, 2

Antiviral Therapy: The Foundation

The cornerstone of treatment is intravenous acyclovir, which should be initiated within 6 hours of admission if viral meningitis is suspected based on clinical presentation and CSF findings, even before PCR confirmation 1, 2. The evidence is clear:

• Dosing: 10 mg/kg IV every 8 hours for adults (>12 years); 500 mg/m² every 8 hours for children 3 months-12 years 1
• Duration: 14-21 days minimum for confirmed HSV-2 meningitis 2
• Monitoring: Reduce dose in renal impairment; maintain adequate hydration to prevent crystalluria and nephropathy (affects up to 20% of patients after 4 days) 1

When to Start Acyclovir

Start immediately if:

• CSF shows lymphocytic pleocytosis consistent with viral meningitis
• Clinical suspicion is high (headache, fever, meningismus, photophobia)
• Results will be delayed beyond 6 hours
• Patient is deteriorating 1, 2

Critical point: Unlike bacterial meningitis, you can perform lumbar puncture before starting treatment in stable patients with mild symptoms, as HSV-2 meningitis progresses more slowly 1. However, CSF PCR remains positive for 7-10 days after starting acyclovir, so delayed LP can still confirm diagnosis 1.

Symptomatic Headache Management

While the guidelines focus primarily on antiviral therapy, headache management follows standard supportive care principles:

• Standard analgesics: NSAIDs, acetaminophen for mild-moderate headache
• Opioids: May be needed for severe headache during acute phase
• Hydration: Maintain adequate IV fluids (also reduces acyclovir nephrotoxicity risk)
• Dark, quiet environment: Helps with photophobia and headache

Important distinction: One study showed pleconaril (an enterovirus-specific drug) reduced headache duration by approximately 2 days in enteroviral meningitis 2, but this is not available for HSV-2 and is not widely used.

Special Considerations for HSV-2 Meningitis

Immunocompetent vs. Immunocompromised Patients

The evidence reveals a crucial distinction:

• Immunocompetent patients: Most recover completely without neurologic sequelae, even without antiviral therapy 3. However, guidelines still recommend treatment to reduce symptom duration and prevent rare complications
• Immunocompromised patients: Significantly improved neurologic outcomes with antiviral therapy (P < 0.05) 3. These patients require full treatment courses and may need prolonged therapy

Recurrent HSV-2 Meningitis (Mollaret's Meningitis)

Do NOT use prophylactic acyclovir or valacyclovir to prevent recurrences 4. This is explicitly stated in UK guidelines. However:

• Recurrence rates can be 26-29% in some populations 1
• Episodes are typically self-limiting in immunocompetent patients 5, 6
• Recent case reports suggest patient-initiated episodic oral valacyclovir at symptom onset may attenuate severity 7, though this is not yet guideline-supported

Duration and Monitoring

Repeat lumbar puncture at 14-21 days to confirm CSF is HSV-2 PCR negative 2:

• If still positive: continue IV acyclovir with weekly CSF PCR until negative
• In children 3 months-12 years: minimum 21 days before repeat LP due to higher relapse rates (up to 29%) 1

Common Pitfalls to Avoid

1. Stopping acyclovir on single negative CSF PCR: If taken <72 hours after symptom onset, PCR may be falsely negative. Repeat in 24-48 hours if clinical suspicion remains high 2

2. Assuming genital herpes history: 83-92% of HSV-2 meningitis patients have NO history of genital herpes, and only 4% have active genital lesions at presentation 6. Don't rule out HSV-2 based on sexual history alone

3. Premature discontinuation: The original 10-day trials showed high relapse rates. Current standard is 14-21 days minimum 2

4. Inadequate hydration: Monitor renal function closely; nephropathy risk increases after 4 days of IV therapy 1

5. Routine corticosteroid use: Do NOT use corticosteroids routinely in HSV meningitis 2. Their role remains controversial and unproven, though a European RCT is ongoing. Consider only in severe cerebral edema under specialist supervision

Treatment Algorithm Summary

1. Suspect HSV-2 meningitis: Headache + fever + meningismus ± photophobia
2. Perform LP (if stable) or start empiric acyclovir immediately (if unstable/deteriorating)
3. Start IV acyclovir 10 mg/kg q8h within 6 hours
4. Confirm diagnosis: CSF PCR for HSV-1, HSV-2, VZV, enteroviruses
5. Continue treatment 14-21 days with adequate hydration
6. Repeat LP at 14-21 days: If PCR still positive, continue weekly until negative
7. Symptomatic headache management: Standard analgesics, hydration, supportive care

The headache itself resolves as the meningitis improves with antiviral therapy; there is no specific "headache treatment" beyond standard analgesics and treating the underlying HSV-2 infection aggressively with acyclovir.